Navigation Links
All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
Date:10/31/2007

POMPANO BEACH, Fla., Oct. 31 /PRNewswire/ -- All-State Properties, L.P. announced today the termination of its agreement with Hubei Longdan Biological Medicine Technology Co., Ltd. which contemplated a reverse merger with the private Chinese pharmaceutical company.

Under the terms of the Acquisition Agreement, Hubei Longdan is obligated to pay all of All-State's expenses relating to the transaction, as well as expenses relating to maintenance of the company and its registration as a public company. In a letter dated today, the chairman of Hubei Longdan advised the company that it was unable or at least unwilling to fulfill its contractual commitment to pay these expenses.

Accordingly, All-State will terminate the Acquisition Agreement based on this breach. As previously mentioned in its filings with the Securities and Exchange Commission, the company intends to dissolve itself now that the Acquisition Agreement has been terminated.


'/>"/>
SOURCE All-State Properties, L.P.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., LOS ANGELES, Dec. 2 A...and Tourism ministerial delegates came together to...ps required to give it the necessary thrust. Organ...ww.medicaltourismassociation.com , the high-powere...rs discussed the opportunities and requests for as...
(Date:12/2/2009)...riad microbes in tobacco, but risk is unclear , ...ew research provides evidence that the average cig...that cause respiratory disease. , But as one sp...hors of the new study aren,t sure what, if any, ha...othing new: Microbes surround us every day of our ...
(Date:12/2/2009)... may not be able to tell a good book by its cover,...k by its smell. In a report in ACS, Analytical Ch...velopment of a new test that can measure the degra...nts based on their smell. The nondestructive "snif...a range of prized paper-based objects, some of whi...
(Date:12/2/2009)...SHINGTON, Dec. 2 Holly Potter, vic...Stakeholder Management for Kaiser Permanente, rece...eople luncheon held at the National Press Club. ...cases the top innovators and professionals who day...n the marketplace. The winners of this year,s prog...
(Date:12/2/2009)...edia Advisory for Thursday, Dec. 3 ,, Head of...cheon Meeting of Army Wounded Warriors; Army Embra...just ,, WASHINGTON, Dec. 2 /PRNewswire-USNewsw...tional Organization on Disability: ,, WHAT: W...y Wounded Warrior (AW2) program,s National Organiz...
Breaking Medicine News(10 mins):Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2
... Blends of Vegetables and Fruits Designed to Tackl...le Consumption, CAMDEN, N.J., March 4 Who knew v...g, the makers of V8(R) juices are rolling,out a ne...rovides a full serving of vegetables and a full se...
...US, Ohio, March 4 The Wallick Companies have,esta...co-founder, Sanford,"Sandy" Goldston, to benefit c... of affordable housing., The Wallick Companies ma...le housing industry lost,a leader, a proponent and...
...to support research into the effects on the brain ... It was announced this,week that The National Aut... Burbacher/Charleston study into the effects of me...dy relating to the,effects upon the brain followin...
...s Offerings to Help Hospitals Prevent Infections, ...provider of products and services that improve the...ounced a definitive agreement to,acquire the asset...e ChloraPrep(R) brand name and is expected to clos...
... One-Third of Surveyed Managed Care Organizations ... Remicade and Humira, According to a New ...M, Mass., March 4 Decision Resources, one of the,...bing Centocor/Schering-Plough/Mitsubishi Tanabe,s ...
...erence Call to Begin Today at 9:00 a.m. ET -, VAL...aq: MNKD ) today reported financial results for t...., For the fourth quarter of 2007, total operatin...lion to $66.8 million,for the fourth quarter of 20...
Other Medicine News:Health News:V8 V-Fusion(R) Takes an Exotic, Tasty Twist on Vegetable Juice 2Health News:The Wallick Companies Establish Sanford Goldston Memorial Fund 2Health News:Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study 2Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 2Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 3Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 4Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 5Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 6Health News:Although Remicade and Humira Are Being Increasingly Prescribed for Crohn's Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies 2Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results 6
(Date:12/2/2009)... , LEXINGTON, Mass. and HEIDELBERG, Ge...s been recognized as one of the winners of the "To...ine. The company,s automated sequence capture tech... due to its exceptional combinations of invention,...ed a panel of expert judges to evaluate a broad ra...
(Date:12/2/2009)... , WESTON, Fla., Dec. 2 /PRNewswire-Fi...(Pink Sheets: ASFX) (the Company), announces that ...pproved home needle destruction device (NDD), is i...cally designed to fill the current demand for home...resulting from the recent passing of the SB 486 ...
(Date:12/2/2009)... , PHILADELPHIA, Pennsylvania, December...NASDAQ: SHPGY ), the global specialty biopharmace...litigation with Teva,Pharmaceuticals USA, Inc. ("T... generic version of ADDERALL XR. Shire has been su...ince April 1, 2009. Shire,s ability to supply,the ...
Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 1Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 2Kidney Community Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Iowa 48347 3Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3
...o facilitate rapid advancement of leading MET ...s -, SOUTH SAN FRANCISCO, Calif., Aug. 23 ,Exelix...has agreed to a,request from GlaxoSmithKline (GSK)...nd reaches proof-of-concept. Exelixis expects to d...K in mid-September, at which point,GSK will begin ...
...PRNewswire-FirstCall/ - Alfacell Corporation,(Nasd... in the International,Journal of Oncology (2007; V... substantially decreases reactive oxygen intermedi...es. The observed antioxidant activity,of ONCONASE ... cells and,mechanistic synergism with other anti-c...
Other Medicine Technology:GlaxoSmithKline Accelerates Review of Exelixis' XL880 2GlaxoSmithKline Accelerates Review of Exelixis' XL880 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: